Verified short-acting forms of TRT at this point include testosterone nasal gel and buccal troches. It appears that absorbing 1-1.5 mg of testosterone via short-acting delivery methods 2-3 times per day does not result in a complete shutdown of the HPTA. I consider this highly desirable, as there are known and likely also unknown negative consequences of the long-term suppression of HPTA hormones, which include kisspeptin, GnRH, LH and FSH.
Admittedly the last thing we need is some other nebulous danger to worry about that may not even exist. Read on at your peril.
TL;DR: Testosterone replacement therapy suppresses the production of GnRH. Receptors for GnRH are found in places besides the pituitary. One animal model suggests GnRH may have health benefits independent of its stimulation of LH and FSH production.
The background: Gonadotropin-releasing hormone, or GnRH, is the signal the hypothalamus uses to tell the pituitary gland to secrete luteinizing hormone and follicle stimulating hormone. Luteinizing hormone (LH)...
TD;LR: Kisspeptin may affect how we act and feel. It seems plausible that a TRT-induced reduction in this hormone is a problem for some men.
I’d
previously asked if suppression of GnRH by TRT is a problem. The literature at least hints that it is possible. The situation with kisspeptin may be similar. The kisspeptin hormone sits near the top of the male sex hormone cascade. It helps stimulate GnRH production, which in turn leads to LH and FSH, which leads to testosterone and then estradiol. Testosterone and estradiol then provide negative feedback for kisspeptin production in the...
Via Natesto, the evidence is showing that short-acting testosterone can alleviate the symptoms of hypogonadism. What you won't get is the boost to athleticism seen with the supraphysiological doses used in some forms of conventional TRT, e.g. injecting 100+ mg TC/week. Some appear to get away with these higher doses, at least in the short run, but others experience side effects, which can include
high hematocrit, elevated estradiol, impaired libido and sexual function, infertility, etc.
The nasal gels and buccal troches are not the most convenient ways to boost testosterone. I have been researching other forms that could also be short-acting, but so far nothing definitive has come of it. Testosterone suspension seems to have both short and long acting behavior. For me, at least, it requires very low doses to maintain HPTA function, even with the help of exogenous kisspeptin(-10) and GnRH. TNE in oil is a question mark. Possibly it has some promise, but so far nobody has done enough testing to see what's really going on with it. I developed a water-based testosterone solution, but I haven't characterized the pharmacokinetics yet and the subjective results have not been that encouraging.
See also:
Lately I’ve been insinuating that some testosterone suspension products may qualify as fast-acting, and therefore be in the same league as testosterone nasal gels and buccal troches. The “fast-acting” quality is important if the goal is to retain HPTA function in the presence of exogenous testosterone. It was time to put my money where my mouth is in order to see what’s actually happening when I inject testosterone suspension.
The results are promising, but not as definitive as I’d hoped for due to some confounding factors.
Materials and Methods
The product used was Pharmacom...